Brief: Anika Therapeutics Reports Q4 2020 Financial Results
04/03/2021 22:37
March 4 (Reuters) - Anika Therapeutics Inc ANIK.O :
* Q4 ADJUSTED EARNINGS PER SHARE $0.12
* Q4 LOSS PER SHARE $1.10
* Q4 REVENUE ROSE 10 PERCENT TO $32.7 MILLION
Source text for Eikon: ID:nGNX6sjRtq
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%